BWM
GILD icon

BNC Wealth Management’s Gilead Sciences GILD Stock Holding History

BNC Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,917
Closed -$121K – 247
2020
Q3 		$121K Buy
+1,917
New +$133K 0.09% 101

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BNC Wealth Management's GILD Position: Q4 2020 in Review

BNC Wealth Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 1,917 shares — an estimated $121K sold.

BNC Wealth Management first reported a position in GILD in Q3 2020 and held it in 1 quarter. The position peaked at $121K in Q3 2020. 1,564 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • BNC Wealth Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • BNC Wealth Management sold 1,917 Gilead Sciences shares in Q4 2020, an estimated $121K.
  • BNC Wealth Management first reported a position in Gilead Sciences in Q3 2020 and held it in 1 quarter.
  • BNC Wealth Management's Gilead Sciences position peaked at $121K in Q3 2020.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on BNC Wealth Management's 13F filing for Q4 2020, filed 5 Mar 2021.